Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis (Q73743100)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

myelodysplastic syndrome

1 reference

1 reference

Yoshihiro Oka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Akihiro Tsuboi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Masaki Murakami

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Manabu Hirai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Nobuhiko Tominaga

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Hiroko Nakajima

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Olga A Elisseeva

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Tomoki Masuda

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Akiko Nakano

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Manabu Kawakami

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Yusuke Oji

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Kazuhiro Ikegame

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Naoki Hosen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Keiko Udaka

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Masaki Yasukawa

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Hiroyasu Ogawa

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Ichiro Kawase

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Haruo Sugiyama

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Hematology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

56-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12894852%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf02983241

6 November 2019

exact match

0 references

cites work

Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers

1 reference

12 December 2020

Expression of the Wilms' tumor gene (WT1) in human leukemias

1 reference

12 December 2020

Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level

1 reference

12 December 2020

Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth

1 reference

12 December 2020

Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination

1 reference

12 December 2020

Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma.

1 reference

12 December 2020

High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients

1 reference

12 December 2020

Cancer immunotherapy targeting Wilms' tumor gene WT1 product

1 reference

12 December 2020

Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells

1 reference

12 December 2020

Wilms' tumor gene WT1: its oncogenic function and clinical application

1 reference

12 December 2020

Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias

1 reference

12 December 2020

Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage

1 reference

12 December 2020

Cancer immunotherapy targeting WT1 protein

1 reference

12 December 2020

CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia

1 reference

12 December 2020

The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

1 reference

12 December 2020

HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria.

1 reference

12 December 2020

Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF).

1 reference

12 December 2020

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

1 reference

12 December 2020

The Wilms' tumor 1 gene: oncogene or tumor suppressor gene?

1 reference

12 December 2020

Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues.

1 reference

12 December 2020

Development of HLA-A2402/K(b) transgenic mice

1 reference

12 December 2020

The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells

1 reference

12 December 2020

Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product

1 reference

12 December 2020

Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis.

1 reference

12 December 2020

WT1 as a novel target antigen for cancer immunotherapy

1 reference

12 December 2020

Immunity to WT1 in the animal model and in patients with acute myeloid leukemia

1 reference

12 December 2020

Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells.

1 reference

12 December 2020

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

1 reference

12 December 2020

Antilung cancer effect of WT1-specific cytotoxic T lymphocytes.

1 reference

12 December 2020

Myelodysplastic syndrome: review of the cytogenetic and molecular data

1 reference

12 December 2020

Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1

1 reference

12 December 2020

Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

1 reference

12 December 2020

Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome

1 reference

12 December 2020

WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia.

1 reference

12 December 2020

Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence-activated cell sorting

1 reference

12 December 2020

Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia

1 reference

12 December 2020

HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide

1 reference

12 December 2020